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ABSTRACT: In a search for new secondary metabolites from mosses, leucobryns A−E, axially chiral 9,10-phenanthrenequinone
dimers, were isolated from Paraleucobryum longifolium (1−5), together with diosmetin triglycoside. Leucobryns B (2) and C (3)
were proved to be homodimeric atropodiastereomers containing both axial and central chirality elements, while leucobryns D (4)
and E (5) were found to be heterodimeric atropodiastereomers containing central chirality in only one of the two monomeric units.
Axial chirality of the compounds was determined by ECD measurements and sTDA ECD calculations, while the central chirality
elements were assigned by TDDFT-SOR calculations. Leucobryns represent the first 9,10-phenanthrenequinone dimers, the
monomers of which are linked through their C-8 atoms. Leucobryns B−E contain an uncommon C10 monoterpenoid side chain, in
which isoprenoid units are joined by 3,4 linkages. Leucobryns A and B exhibited weak antiproliferative activity against several human
cancer cell lines.
Bryophytes, comprising about 23 000 species worldwide,are a source of structurally unique, bioactive compounds.
Although the phytochemical and pharmacological potential of
bryophytes is poorly explored because of the difficulties of their
collection and botanical identification, numerous new com-
pounds have been discovered from liverworts so far, including
more than 40 new carbon skeletons of terpenoids and phenolic
compounds.1−5 Many moss species have been used as
medicinal plants for infections and neurological disorders
and also for their nutritional value.3−5 The biological effects
ascribed to the compounds identified in liverworts are mainly
related to cytotoxic, antimicrobial, antifungal, antiviral,
insecticide, nematocide, enzyme inhibitory, antiallergic, muscle
relaxant, and antioxidant activities.3−6 Mono-, sesqui-, di-, and
triterpenoids, highly unsaturated fatty acids, flavonoids,
bibenzyls, bis-bibenzyls, acetogenins, and phenanthrenes are
the main chemical types of secondary metabolites of
liverworts.3−5
Paraleucobryum longifolium (Ehrh. ex Hedw.) Loeske,
belonging to the Dicranaceae family, is widely distributed in
North America, Russia, and Europe. The plant grows on cliffs,
tree trunks, stumps, and rotten logs, at moderate to high
(400−2900 m) altitudes.7 P. longifolium was investigated
earlier for lipid constituents; wax esters, hydrocarbons, and
steryl esters have been described from the plant.8 In the
present study, secondary metabolites of P. longifolium were
analyzed with special attention to the pigments with a violet
color. Herein, we report the isolation, structure determination,
and pharmacological evaluation of five new 9,10-phenanthre-
nequinone dimers, named leucobryns A−E (1−5).
■ RESULTS AND DISCUSSION
P. longifolium was extracted with MeOH, and the evaporated
extract was subjected to column chromatography (CC) on
polyamide. Fractions eluted with 80% MeOH displayed a
strong violet color. Dark violet compounds 1−5 were isolated
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using vacuum liquid chromatography, gel filtration on
Sephadex LH-20, and RP-HPLC.
Compound 1 was obtained as a dark violet amorphous
powder with UV maxima at 542.5, 370, 305, 272, and 213.5
nm. The molecular formula was established as C40H38O12
based on HRESIMS data, which showed the sodium adduct
ion [M + Na]+ at m/z 733.2252 (calcd for 733.2255
C40H38O12Na). The
13C JMOD spectrum displayed 20
resonances, which indicated that compound 1 is a symmetric
dimer (Figure 1).
The monomeric moiety of the molecule is constructed by 10
nonprotonated carbons (δC 71.98, 118.00, 121.19, 129.50,
131.07, 131.23, 133.91, 155.84, 156.81, and 157.65), two
carbonyl (δC 192.01 and 192.77), three methines (δC 107.65,
122.06, and 129.97), two methylenes (δC 23.07 and 44.21), a
methoxy group (δC 56.29), and two methyls (δC 28.86 and
28.99) (Table 1). The evaluation of 1D 1H and 2D 1H−1H
COSY spectroscopic data revealed the presence of two ortho-
doublets (δH 8.44 d, 7.04 d), an isolated aromatic proton (δH
6.79 s), an ethylene group (δH, 3.00 td, 2.87 td, 1.74 td, 1.65
td), two methyls [δH 1.28 s (6H)], and a methoxy group [δH
3.65 s (3H)] (Table 2). HMBC correlations between H-6 and
C-5, C-7, C-8, and C-5a, between H-3 and C-1, C-2, C-4, and
C-4a, and between H-4 and C-2, C-1a, and C-10 disclosed that
compound 1 contains a 9,10-phenanthrenedione parent system
with O-functionalities at C-2 (δC 155.84), C-5 (δC 156.81),
and C-7 (δC 157.65) and C-functionalities at C-1 (δC 133.91)
and C-8 (δC 121.19) (Figure 2). The alternative anthraqui-
none structure was ruled out because the strong HMBC cross-
peak observed between H-4 and C-5a suggested that they are
separated by three rather than four bonds. The other three-
bond correlations of H-4 with C-2 and C-1a had similar
intensities. On the other hand, a weak four-bond heteronuclear
interaction was detected between H-4 and the carbonyl carbon
Figure 1. Structures of leucobryns A−E (1−5).
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at δC‑10 192.77. Furthermore, the proposed structure was
confirmed by a weak cross-peak exhibited between H-6 and C-
4a, which would not be expected in an anthraquinone, due to
the long distance (5 bonds) between these atoms.
The presence of the methoxy group at C-7 was established
by HMBC correlations between the OCH3 protons and C-7
and C-6 and by a NOESY cross-peak between H-6 and the
OCH3 group. A 3-hydroxyisopentyl substituent was corrobo-
rated with the HMBC cross-peaks observed between the
methyl protons at δH 1.28 (H3-14, H3-15) and C-13 (δC 71.98)
and C-12 (δC 44.21); this group was placed at C-1 on the basis
of the H-11/C-1, H-11/C-1a, H-11/C-2, and H-12/C-1
HMBC correlations. A hydroxy group, concluded from the
HRESIMS data, is attached at C-7, as confirmed by its
chemical shift value of δC 157.65. In accordance with all these
data, the structure of compound 1, named leucobryn A, could
be established as a dimer in which the monomers are
connected via their C-8 atoms as depicted in Figure 1.
Compound 2 possessed a molecular formula of C50H54O12
as determined by the HRESIMS ion at m/z 869.3505 [M +
Na]+ (calcd for 869.3507, C50H54O12Na). The
1H NMR and
13C JMOD spectra revealed a structure containing 25 carbon
atoms only, suggesting a symmetric dimeric structure, similarly
to compound 1. The 1H NMR and 13C JMOD spectra of 2
also resembled those of 1. In particular, the 1H and 13C
chemical shifts of the 9,10-phenanthrenedione part were close
to those of 1 (Tables 1 and 2). The main differences were
found in the C5 prenyl side chain, which was changed to a C10
moiety in 2. Combined analysis of 1H NMR, 13C JMOD, and
HSQC spectra proved that this C10 substituent consists of a
nonprotonated, oxygenated carbon (δC 71.46), a disubstituted
carbon−carbon double bond (δH 4.41 d, 4.57 dq; δC 112.61,
148.85), three sp3 methylenes [δH 1.25 m, 1.36 m, 1.48 m
(2H), 2.97 dd, 3.15 dd; δC 28.28, 31.26, 42.85], a methine (δH
2.31 m; δC 50.13), and three methyl groups (δH 1.11 s, 1.12 s,
1.64 br s; δC 18.56, 28.88, 29.30). Based on the
1H−1H COSY
spectrum, two structural fragments could be unambiguously
assigned for the C10 part: −CH2−CHR−CH2−CH2− (A) and
CH2(CH3)C− (B) (Figure 3).
Structural fragment A (C-11−C-12−C-16−C-17) was
connected to the phenanthrenedione skeleton based on the
long-range C−H correlations of H-11/C-1a, H-11/C-1, and
H-11/C-2. In addition, a 2-hydroxyisopropyl group, attached
to C-17, was confirmed by the HMBC correlations between
H3-19/C-17, H3-19/C-18, and H3-20/C-17. HMBC cross-
peaks between H-14/C-12, H-15/C-12, and H-12/C-13
unambiguously established that unit B (C-13−C-14−C-15)
is linked to C-12. The data above provided evidence for a C10
monoterpene side chain, in which, interestingly, the isoprenoid
units are joined by 3,4 linkages, instead of the regular head-to-
tail, tail-to-tail, or head-to-head connection. Collectively, the
structure of compound 2 was established as shown in Figure 1
and named leucobryn B.
Compound 3 (leucobryn C) was isolated the same way as 2,
and in the final step of the purification procedure compounds 2
and 3 were separated by RP-HPLC. The HRESIMS data of 3
displayed a sodium adduct ion at m/z 869.3507 [M + Na]+,
indicating the same molecular formula of C50H54O12 as that of
compound 2. 1D and 2D 1H/13C NMR characteristics of 2 and
3 were similar, with only minute differences observed in the
chemical shifts of H-14, H-16, C-10, C-11, and C-14 (Tables 1
and 2). These data suggest that the structural differences are
explicable in terms of the stereochemistry of the compounds.
Compound 4 (leucobryn D) was isolated as a dark violet
amorphous solid. HRESIMS data revealed a molecular formula
of C45H46O12 according to the sodium adduct ion at m/z
801.2876 [M + Na]+ (calcd for C45H46O12Na 801.2881).
1H
NMR and 13C JMOD data contained signals similar to the
resonances of both compounds 1 and 2 (Tables 1 and 2),
Table 1. 13C NMR Data of Compounds 1−5 (Methanol-d4,
T = 298 K, δ ppm)
position 1a 2b 3b 4b 5b
1 133.91 132.32 132.30 132.29 132.30
1a 129.50 130.39 130.20 130.21 130.37
2 155.84 156.31 156.35 156.35 156.31
3 122.06 121.70 121.81 121.81 121.69
4 129.97 129.95 129.98 129.97 129.95
4a 131.07 130.94 131.10 131.09 130.95
5 156.81 156.73 156.74 156.75 156.71f
5a 118.00 118.15 118.12 118.13 118.13
6 107.65 107.62 107.60 107.65 107.67g
7 157.65 157.44 157.78 157.61 157.47e
8 121.19 120.83 120.96 120.97 120.95c
8a 131.23 131.14 130.94 130.95c 130.91h
9 192.01 n. o. 192.38 192.44d 192.68d
10 192.77 192.06 193.57 193.68 193.81
11 23.07 31.26 31.84 31.22 31.25
12 44.21 50.13 50.02 50.04 50.12
13 71.98 148.85 149.07 149.07 148.83
14 28.99 112.61 112.29 112.30 112.60
15 28.86 18.56 18.59 18.58 18.54
16 28.28 28.04 28.05 28.13
17 42.85 42.84 42.83 42.85
18 71.46 71.47 71.46 71.46
19 29.30 29.30 29.28 29.30
20 28.88 28.86 29.00 28.99
1′ 133.91 132.32 132.30 133.92 133.92
1′a 129.50 130.39 130.20 129.51 129.52
2′ 155.84 156.31 156.35 155.84 155.84
3′ 122.06 121.70 121.81 122.06 122.05
4′ 129.97 129.95 129.98 129.97 129.95
4a′ 131.07 130.94 131.10 131.25 131.25
5′ 156.81 156.73 156.74 156.88 156.79f
5a′ 118.00 118.15 118.12 118.01 118.01
6′ 107.65 107.62 107.60 107.65 107.60g
7′ 157.65 157.44 157.78 157.85 157.60e
8′ 121.19 120.83 120.96 121.17 121.06c
8a′ 131.23 131.14 130.94 131.09c 131.25h
9′ 192.01 n. o. 192.38 191.98d 191.96d
10′ 192.77 192.06 193.57 192.67 192.68
11′ 23.07 31.26 31.24 23.06 23.07
12′ 44.21 50.13 50.02 44.21 44.22
13′ 71.98 148.85 149.07 71.98 71.98
14′ 28.99 112.61 112.29 28.86 28.88
15′ 28.86 18.56 18.59 28.86 28.88
16′ 28.28 28.04
17′ 42.85 42.84
18′ 71.46 71.47
19′ 29.30 29.30
20′ 28.88 28.86
7-OCH3, 56.29 56.27 56.28 56.28 56.28
7′-OCH3 56.29 56.27 56.28 56.28 56.28
a125 MHz. b175 MHz; n.o. not observed. c,d,e,f,g,hSignals in each
column are interchangeable.
Journal of Natural Products pubs.acs.org/jnp Article
https://dx.doi.org/10.1021/acs.jnatprod.9b00655
J. Nat. Prod. 2020, 83, 268−276
270
indicating that compound 4 is a heterodimer constructed by
the monomeric moieties of 1 and 2. As in compounds 1 and 2,
the monomeric constituents of 4 are connected via their C-8
atoms. 2D NMR studies provided further evidence to confirm
the structure of this compound as depicted in structural
formula 4.
Compound 5 (leucobryn E) was separated from 4 by RP-
HPLC using a gradient system of MeCN−H2O mixtures. All
HRESIMS and NMR characteristics of compound 5 were
highly similar to those of 4, suggesting a molecular pair with
the same 2D structure, but with different chirality.
In addition, diosmetin 7-O-[2,4-di-O-(α-L-rhamnopyrano-
syl)]-β-D-glucopyranoside was also isolated from P. longifolium
and identified based on NMR data (Table S1, Supporting
Information).
For the configurational assignment of the axial chirality
elements of 1−5, conformational analysis and the sTDA
(simplified Tamm−Dancoff approximation) approach9 were
applied on the arbitrarily chosen (aS,12R,12′R)-2 and
(aR,12R,12′R)-3 stereoisomers differing in the axial chirality.
When both central and axial chirality elements are present in
biaryl compounds, the ECD spectrum is governed by the axial
chirality element, which can be elucidated by ECD
calculations.10 The experimental ECD spectrum of 1,
Table 2. 1H NMR Data of Compounds 1−5 in Methanol-d4 at T = 298 K (δ ppm, J Hz)
position 1a 2b 3b 4b 5b
3 7.04, d (8.9) 7.00, d (8.9) 7.01, d (8.9) 7.01, d (8.9) 7.01, d (8.9)
4 8.44, d (8.9) 8.40, d (8.9) 8.38, d (8.9) 8.39, d (8.9) 8.39, d (8.9)
6 6.79, s 6.78, s 6.79, s 6.79, s 6.79, s
11a 3.00, td (11.6, 4.9) 3.15, dd (12.7, 8.0) 3.14, dd (12.6, 7.2) 3.13, dd (12.6, 7.2) 3.15, dd (12.5, 8.1)
11b 2.87, td (11.6, 4.9) 2.97, dd (12.7, 6.5) 2.97, dd (12.6, 7.2) 3.02, m 2.97, dd (12.5, 6.5)
12a 1.74, td(12.7, 5.0) 2.31, m 2.30, m 2.30, m 2.31, m
12b 1.65, td (12.7, 5.0)
14a 1.28, s 4.57, dq (2.3, 1.4) 4.54, dq (2.3, 1.4) 4.59, br s 4.57, br s
14b 4.41, d (2.3) 4.47, d (2.3) 4.46, br s 4.40, br s
15 1.28, s 1.64, br s 1.67, br s 1.67, s 1.64, s
16 1.48, m (2H) 1.41, m (2H) 1.41, m (2H) 1.47, m (2H)
17 1.36, m 1.35, m 1.34, m 1.36, m
1.25, m 1.21, m 1.21, dd (13.0, 4.3) 1.25, m
19 1.12, s 1.11, s 1.10, s 1.12, s
20 1.11, s 1.09, s 1.09, s 1.11, s
3′ 7.04, d (8.9) 7.00, d (8.9) 7.01, d (8.9) 7.04, d (8.9) 7.05, d (9.0)
4′ 8.44, d (8.9) 8.40, d (8.9) 8.38, d (8.9) 8.45, d (8.9) 8.45, d (8.8)
6′ 6.79, s 6.78, s 6.79, s 6.80, s 6.79, s
11′a 3.00, td (11.6, 4.9) 3.15, dd (12.7, 8.0) 3.15, dd (12.6, 7.2) 3.00, m 3.00, td (11.9, 4.7)
11′b 2.87, td (11.6, 4.9) 2.97, dd (12.7, 6.5) 2.97, dd (12.6, 7.2) 2.89, td (11.8, 4.7) 2.89, td (11.6, 4.7)
12′a 1.74, td(12.7, 5.0) 2.31, m 2.30, m 1.73, td (13.0, 4.7) 1.74, td (13.0, 4.7)
12′b 1.65, td (12.7, 5.0) 1.66, m 1.68, td (12.3, 4.6)
14′a 1.28, s 4.57, dq (2.3, 1.4) 4.54, dq (2.3, 1.4) 1.27, s 1.28, s
14′b 4.41, d (2.3) 4.47, d (2.3)
15′ 1.28, s 1.64, br s 1.67, br s 1.27, s 1.28, s
16′ 1.48, m (2H) 1.41, m (2H)
17′ 1.36, m 1.35, m
18′ 1.25, m 1.21, m
19′ 1.12, s 1.11, s
20′ 1.11, s 1.09, s
7-OCH3 3.65, s 3.65, s 3.67, s 3.66, s 3.65, s
7′-OCH3 3.65, s 3.65, s 3.67, s 3.66, s 3.65, s
a500 MHz. b700 MHz.
Figure 2. Key 2D NMR correlations in compound 1;― bold line:
1H−1H COSY, → red arrows: HMBC, ↔ blue arrow: NOESY.
Figure 3. Key 2D NMR correlations in the monoterpenoid part of 2;
― bold line: 1H−1H COSY, → red arrows: HMBC.
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containing only an axial chirality element, was found to be
similar to those of 2 and 4, but with weaker intensity, and
nearly mirror-images of the ECD spectra of 3 and 5 were
recorded, indicating that the central chirality elements of 2−5
do not significantly contribute to the ECD spectra (Figure 4a).
In axially chiral biaryls, the absolute configuration of the
central chirality elements was determined by ECD analysis of
the monomers co-isolated from the same source11,12 or,
alternatively, by VCD calculations.13 The configurational
assignment of both central and axial chirality elements in
axially chiral natural biaryls is considered a challenging task by
even the combination of different chiroptical methods and
their computation.10a,11a,14 Owing to the substitution pattern
in the ortho-positions of the biaryl axis, biaryls 1−5 were
expected to have a rotational energy barrier exceeding 93.6 kJ/
mol, which is considered the minimum rotational energy
barrier for the presence of separable atropisomers.15
Biaryls 1−5 are expected to have a large number of ECD
transitions to compute, which required the use of the sTDA
method9c,d developed for large molecules and/or for
compounds with a large number of ECD transitions. This
method was developed for complex molecules, the TDDFT
calculation of which would be quite demanding computation-
ally or not feasible at an advanced DFT level. Despite the
strengths of this method, there are only a few examples for
application in the field of natural products.16,17 The initial
Merck Molecular Force Field (MMFF) conformational search
of (12R,12′R)-2/3 resulted in 1326 conformers in a 21 kJ/mol
energy window, including both the (aS,12R,12′R)-2 and
(aR,12R,12′R)-3 stereoisomers, which were separated man-
ually. Subsequently, they were reoptimized at the AM1 semi-
empirical level to reduce the number of conformers18 and then
at the CAM-B3LYP/TZVP19 PCM/MeCN level.
sTDA-ECD calculations were performed for conformers
above 1% population at the CAM-B3LYP, LC-BLYP,20 and
ωB97X21 levels, for which the required single-point calcu-
lations were performed with the same functionals and the
TZVP basis set. All of the Boltzmann-averaged ECD spectra of
(aS,12R,12′R)-2 and (aR,12R,12′R)-3 consistently gave
moderate to good agreement with the experimental ECD
spectrum of 2 and 3, respectively, and all the low-energy
conformers of the same axial chirality exhibited similar ECD
spectra, permitting the elucidation of the absolute confi-
guration of the axial chirality as (aS) in 2 and (aR) in 3 (Figure
4b and Figure 5).
Thus, compounds 2 and 3 are atropodiastereomers with
identical absolute configuration of their stereogenic centers.
Comparing the ECD spectra of 1, 4, and 5 to those of 2 and 3
revealed the absolute configuration of 1 and 4 as (aS) and that
of 5 as (aR) (Figure 4a).
Since both the experimental and computed ECD spectra of
(aS,12R,12′R)-2 and (aR,12R,12′R)-3 showed a mirror-image
relationship, in principle the determination of the central
chirality element was not feasible with the ECD spectra.
However, the experimental specific rotation (SR) values of 2
and 3 had different magnitudes with opposite signs [2: [α]23D
= +162, 3: [α]23D = −222], which suggested that the SR values
are also influenced by the central chirality elements, although
the different signs derived from the different axial chirality. In
order to elucidate the absolute configuration of the central
chirality elements, SR calculations of (aS,12R,12′R)-2 and
(aR,12R,12′R)-3 were performed on the CAM-B3LYP/TZVP
PCM/acetone conformers.22 Considering that 2 and 3 are
Figure 4. (a) Comparison of the experimental ECD spectra of 1−5
measured in MeCN; (b) comparison of the experimental ECD
spectrum of 2 in MeCN to the sTDA-CAM-B3LYP spectrum of
(aS,12R,12′R)-2 computed from the CAM-B3LYP/TZVP single-
point data. Level of optimization: CAM-B3LYP/TZVP PCM/MeCN.
Bars represent the rotational strength values of the lowest-energy
conformer.
Figure 5. Comparison of the experimental ECD spectrum of 3 in
MeCN with the sTDA-CAM-B3LYP ECD spectrum of
(aR,12R,12′R)-3 computed from the CAM-B3LYP/TZVP single-
point data. Level of optimization: CAM-B3LYP/TZVP PCM/MeCN.
Bars represent the rotational strength values of the lowest-energy
conformer.
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homodimers with identical C-12 and C-12′ absolute
configuration in the monomeric units, the (aS,12R,12′R)-2
and (aR,12R,12′R)-3 stereoisomers fully cover all four
possibilities. In line with the ECD results, Boltzmann-averaged
SR values computed at four levels of theory for (aS,12R,12′R)-
2 showed consistently positive values ranging from 46.5 to
161.6 vs the experimental SR value of 162, while those
computed for (aR,12R,12′R)-3 gave negative values with larger
magnitude in the range of −102.8 to −234.0 vs the
experimental SR of −222. Although the magnitude of
computed SRs can be considerably different from that of the
experimental ones,23 all four applied combinations of levels
showed a clear tendency with larger absolute values for the
(aR,12R,12′R) configuration compared to those of
(aS,12R,12′R). A good agreement for the B3LYP/TZVP
PCM/acetone // CAM-B3LYP/TZVP PCM/acetone level
[161.6 vs experimental 162 for (aS,12R,12′R)-2 and −234.0 vs
experimental −222 for (aR,12R,12′R)-3)] permitted a
probable assignment of the central chiral i ty as
(aS,12R,12′R)-2 and (aR,12R,12′R)-3. The wavelength of
experimental SR values measured at the sodium D line (589.3
nm) falls in the higher-wavelength range of the highest-
wavelength ECD transition of 2 and 3, and they had the same
signs as those of the corresponding ECD transition.24 In order
to check that the SR values of 2 and 3 recorded at 589.3 nm
belong to the monotonously increasing wavelength range of
the ORD spectrum without a change of sign (ORD anomaly)
or they contain the effect of the ORD anomaly, SR values of
(aS,12R,12′R)-2 and (aR,12R,12′R)-3 were calculated at 10
selected wavelengths in the range of 575−800 nm with four
methods (Figures 6 and 7). These SR calculations consistently
showed that there was no sign inversion of SR values in the
600−800 nm wavelength range, while anomalous ORD
appears around the wavelength of the sodium D line. The
ORD anomaly expected below 600 nm and the MMFF-AM1-
clustering-DFT reoptimization sequence for the conforma-
tional analysis to reproduce the biaryl dihedral angles and the
side-chain conformation may expose some uncertainty in the
determination of the central chirality. However, the computed
SR values clearly support the conclusion, and characteristic
differences in the magnitudes of the computed SR values for
(aS,12R,12′R)-2 and (aR,12R,12′R)-3 appeared consistently at
all the computed wavelengths.25
The SR calculations of (aS,12R,12′R)-2 and (aR,12R,12′R)-
3 represent the first example to determine the central chirality
of a homodimeric biaryl natural product in the presence of
axial chirality on the basis of the SR calculations. VCD
measurement and calculations were reported earlier to
determine both axial and central chirality for the biaryl natural
product (aS,2R,2′R)-cephalochromin, the SR calculation of
which could not decide on the central chirality.13 However, the
same VCD approach failed to determine the central chirality of
flavomannin A in the presence of axial chirality.10a SR
calculations were also successfully utilized to determine the
central chirality of quinolinophane derivatives containing both
planar and central chirality elements.26 The recent example of
leucobryns B and C also demonstrated that the specific
rotation values can contain stereochemical information, which
are either missing from or supplementary to the ECD data, and
it can be utilized to determine stereochemical properties,
which would not be feasible by using only ECD calculations.
Phenanthrenes are characteristic compounds of bryophytes.
The first derivative, 2-hydroxy-3,7-dimethoxyphenanthrene,
was isolated from Marchantia polymorpha by Asakawa et al.27
To date, about two dozen compounds belonging to
phenanthrenes, 9,10-dihydrophenanthrenes, biphenanthrenes,
and bisbibenzyl-phenanthrenes were isolated from different
genera of bryophytes.1,28−36 Leucobryns (1−5) are the first
representatives of dimeric phenathrenes with a 9,10-ortho-
quinone structure. Monomeric 9,10-phenanthraquinones are
extremely rare in nature: previously such compounds have only
been isolated from some lichens,37 bacteria,38−40 and vascular
plant species.41,42 9,10-Phenanthraquinones produced by
microorganism have been reported to have strong antibiotic
properties and antiviral activity.35,36
The possible biogenetic origin of phenanthraquinones is
rarely discussed in the literature. Regarding their oxygenation
patterns, acetate-derived polyketide biogenesis was suggested
for some phenanthraquinones based on isotope feeding
experiments.36,43,44 On the other hand, phenanthrenes can be
formed by intramolecular oxidative ortho-coupling of dihydro-
Figure 6. Average SR values of (aS,12R,12′R)-2 computed at various
wavelengths at four levels of theory (red: B3LYP/TZVP PCM/
acetone, blue: BH&HLYP/TZVP PCM/acetone, orange: CAM-
B3LYP/TZVP PCM/acetone, purple: PBE0/TZVP PCM/acetone)
with the TZVP basis set and PCM solvent model for acetone. Level of
optimization: CAM-B3LYP/TZVP PCM/acetone.
Figure 7. Average SR values of (aR,12R,12′R)-3 computed at various
wavelengths at four levels of theory (red: B3LYP/TZVP PCM/
acetone, blue: BH&HLYP/TZVP PCM/acetone, orange: CAM-
B3LYP/TZVP PCM/acetone, purple: PBE0/TZVP PCM/acetone)
with the TZVP basis set and PCM solvent model for acetone. Level of
optimization: CAM-B3LYP/TZVP PCM/acetone.
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stilbenes (bibenzyls).45 In such cases the hydroxylation/
methoxylation pattern of at least one of the two aromatic
rings in phenanthrene corresponds to the 3,5-disubstitution
pattern of stilbenes. This structural feature is also characteristic
of leucobryns. Considering that bibenzyls and bis-bibenzyls
belong to the most important secondary metabolites of
bryophytes, their biogenetic relationship with dimeric phenan-
thraquinones can be accepted. The occurrence of bibenzyl−
phenanthrene and bibenzyl−dihydrophenanthrene compounds
in some bryophytes (Buzzania and Cavicularia species)24,25
provides further evidence for the presumption that leucobryns
are biosynthesized by dimerization of bibenzyls with a C−C
linkage, followed by oxidative steps yielding a 9,10-dioxo
functionality. Similar to leucobryns 1−5, certain bibenzyls are
also substituted with prenyl or geranyl groups.1,2
The antiproliferative action of the isolated compounds (1−
5) was determined against four human cancer cell lines of
gynecological origin, but only moderate (<10 μM) or
negligible activities were measured (Table S6).
■ EXPERIMENTAL SECTION
General Experimental Procedures. UV spectra were measured
on a Shimadzu UV-1800 UV−vis spectrophotometer in MeOH. The
NMR spectra were recorded in methanol-d4 on a Bruker Avance DRX
500 spectrometer operating at 499.9 MHz for 1H and 125.7 MHz for
13C and a Bruker Avance NEO 700 spectrometer operating at 700.25
MHz (1H) and 176.08 MHz (13C), respectively. All measurements
were performed at 298 K. The signals of the methanol-d4 (
1H: 3.35
ppm, 13C: 49.3 ppm) were taken as reference. 2D NMR data were
acquired and processed with Bruker TopSpin 4.0.5 software. Standard
pulse programs available in the Bruker library were used for 2D
1H−1H magnitude COSY (cosygpqf), gradient- and sensitivity-
enhanced HSQC (hsqcetgps i sp2 .2) , magnitude HMBC
(hmbcgplpndqf), and EASY-ROESY (roesyadjsph) experiments. The
high-resolution MS spectra were acquired on an FTHRMS-Orbitrap
(Thermo-Finnigan) mass spectrometer equipped with an ESI ion
source in positive ionization mode. HPLC was performed on a Waters
600 HPLC system (Waters Corporation, Milford, USA), equipped
with a 2998 photodiode array detector and online degasser. ECD
spectra were recorded on a JASCO J-810 spectropolarimeter. Solvents
were distilled prior to use, and spectroscopic grade solvents were
applied for spectroscopic measurements.
Plant Material. Paraleucobryum longifolium (Dicranaceae) was
collected in Mat́rafüred (Hungary) in June 2016. A voucher specimen
(No. 883) has been deposited in the Herbarium of the Department of
Pharmacognosy of University of Szeged, Szeged, Hungary. The plant
material was dried at room temperature and chopped in a Retsch SM
100 chopper.
Extraction and Isolation. The plant material (4.0 kg) was
extracted in a percolator with 75 L of MeOH at room temperature.
The extract was evaporated (331.1 g) and the residue was subjected
to column chromatography on polyamide using MeOH−H2O
mixtures (20%, 40%, 60%, 80%, 100%). Fractions obtained with
80% MeOH contained compounds with a violet-black color. The 80%
MeOH fraction was further separated by vacuum liquid chromatog-
raphy (VLC) on normal-phase silica gel (particle size 45−63 μm)
with a gradient system of CHCl3−MeOH (10:0, 9.6:0.4, 9.3:0.7, 9:1,
8:2, 7:3, and 0:1). This separation yielded 12 subfractions; among
them subfractions 9−12 contained a MeOH-soluble, but a CHCl3-
insoluble violet-black material, and subfraction 9 was chosen for
further purification on NP-CC (silica gel, particle size 45−63 μm)
using toluene−CHCl3−MeOH (4:12:3) as eluent. This chromatog-
raphy afforded subfractions A−I; the violet-black material was
concentrated in subfractions D, E, and F. Subfraction D was separated
by reversed-phase flash chromatography (FC) using a gradient system
of MeCN−H2O mixtures (from 50% to 50% to 100% MeCN)], then
by gel filtration on Sephadex LH-20 eluted with MeOH, and finally by
RP-HPLC on a Kinetex XB-18 column (100 A, 250 × 4.6 mm, 5 μm,
Phenomenex, Torrance, CA, USA) using a H2O−MeCN gradient
system (0 min: H2O−acetonitrile 6:4, 1 min: 6:4, 10 min: 4:6, 11
min: 1:9, 12 min: 6:4, 17 min: 6:4) as eluent at a flow rate of 1.5 mL/
min. By this means leucobryn B (2) (0.8 mg, tR = 9.95 min) and
leucobryn C (3) (0.65 mg, tR = 10.27 min) were separated.
Subfraction E was chromatographed on Sephadex LH-20 eluted with
MeOH and further purified by RP-HPLC on a Kinetex XB-18
column. The detection was in the full UV wavelength range. Elution
was carried out with the gradient system of H2O−MeCN (0 min:
H2O−MeCN 65:35, 1 min: 65:35, 10 min: 62:38, 12 min: 62:38, 13
min: 0:100, 13.5 min: 65:35, 18 min: 65:35) at a flow rate of 1.5 mL/
min, affording leucobryn E (5) (0.6 mg, tR = 14.42 min) and
leucobryn D (4) (0.6 mg, tR = 14.96 min). Subfraction F was
chromatographed on Sephadex LH-20 with MeOH, yielding the pure
compound leucobryn A (1) (3.6 mg). The 60% MeOH fraction of the
polyamide column was subjected to VLC on normal-phase silica gel
(particle size 45−63 μm) using a gradient system of cyclohexane−
CHCl3−MeOH (90:9.9:0.1, 80:19.8:0.2, 70:29.7:0.3, 0:9:1, 0:8:2,
0:7:3, 0:6:4, 0:5:5, 0:4:6, 0:3:7, 0:2:8, and 0:0:1). The separation
yielded subfractions A−R, and subfraction M was selected for further
purification on RP-VLC with a gradient system of H2O−MeOH (6:4,
5:5, 4:6, 3:7, 2:8, and 0:1) and yielded subfractions 1−9. Subfraction
1 was purified by gel filtration on Sephadex LH-20 with MeOH and
by RP-HPLC on Kinetex C-18 (100 A, 150 × 4.6 mm, 5 μm,
Phenomenex) using a H2O−isopropanol (IPA) gradient system (0
min: H2O−IPA 9:1, 1 min: 9:1, 10 min: 4:6, 11 min: 3:7, 12 min: 9:1,
18 min: 9:1) as eluent at a flow rate of 1 mL/min. This separation
afforded diosmetin 7-O-[2,4-di-O-(α-L-rhamnopyranosyl)]-β-D-gluco-
pyranoside (tR = 9.93 min). This compound was described previously
from the bryophyte Dicranum scoparium Hedw.46
Leucobryn A (1): purple, amorphous solid; [α]23D +316 (c 0.03,
acetone); UV λmax (log ε) 542.5 (3.40), 370 (3.55), 305 (4.14), 272
(4.50), 213.5 (4.64) nm; ECD (MeCN, λ [nm] (Δε), c 0.087 mM)
550 (+0.75), 441 (−0.33), 318sh (−0.67), 291 (−0.92), 248 (+1.53),
221sh (−0.25); 1H NMR (700 MHz, methanol-d4) see Table 1; 13C
NMR (175 MHz, methanol-d4) see Table 2; HRESIMS (positive) m/
z 733.2252 [M + Na]+, calcd for 733.2255 C40H38O12Na, m/z
749.2002 [M + K]+, calcd for 749.1995 C40H38O12K.
Leucobryn B (2): purple, amorphous solid; [α]23D +162 (c 0.07,
acetone); ECD (MeCN, λ [nm] (Δε), c 0.066 mM) 547 (+4.36), 441
(−1.26), 316sh (−4.27), 289 (−8.01), 249 (+8.09), 218 (−4.43); 1H
NMR (700 MHz, methanol-d4) see Table 1;
13C NMR (175 MHz,
methanol-d4) see Table 2; HRESIMS (positive) m/z 869.3505 [M +
Na]+, calcd for 869.3507 C50H54O12Na, m/z 885.3249 [M + K]
+,
calcd for 885.3247 C50H54O12K.
Leucobryn C (3): purple, amorphous solid; [α]23D −222 (c 0.08,
acetone); ECD (MeCN, λ [nm] (Δε), c 0.044 mM) 540 (−2.99),
446 (+0.67), 313sh (+3.09), 291 (+4.66), 254 (−4.17), 247sh
(−3.98), 216sh (+2.85); 1H NMR (700 MHz, methanol-d4) see
Table 1; 13C NMR (175 MHz, methanol-d4) see Table 2; HRESIMS
(positive) m/z 869.3507 [M + Na]+, calcd for 869.3507
C50H54O12Na, m/z 885.3258 [M + K]
+, calcd for 885.3247
C50H54O12K.
Leucobryn D (4): purple, amorphous solid; [α]23D +160 (c 0.07,
acetone); ECD (MeCN, λ [nm] (Δε), c 0.064 mM) 577 (+6.09), 431
(−1.26), 314sh (−8.19), 295 (−11.52), 255sh (12.08), 248 (+13.19),
221sh (−1.11); 1H NMR (700 MHz, methanol-d4) see Table 1; 13C
NMR (175 MHz, methanol-d4) see Table 2; HRESIMS (positive) m/
z 801.2874 [M + Na]+, calcd for 801.2881 C45H46O12Na, m/z
817.2624 [M + K]+, calcd for 817.2621 C45H46O12K.
Leucobryn E (5): purple, amorphous solid; [α]23D −357 (c 0.03,
acetone); ECD (MeCN, λ [nm] (Δε), c 0.065 mM) 575 (−4.77),
436 (+1.03), 317sh (+6.83), 297 (+9.56), 258sh (−8.63), 248
(−9.77), 220sh (+0.94); 1H NMR (700 MHz, methanol-d4) see
Table 1; 13C NMR (175 MHz, methanol-d4) see Table 2; HRESIMS
(positive) m/z 801.2876 [M + Na]+, calcd for 801.2881
C45H46O12Na, m/z 817.2617 [M + K]
+, calcd for 817.2621
C45H46O12K.
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Computational Section. Mixed torsional/low-frequency mode
conformational searches were carried out by means of the
MacroModel 10.8.011 software by using the MMFF with an implicit
solvent model for CHCl3.
47 Geometry reoptimizations were carried
out first at the semiempirical AM1 level and then at the CAM-
B3LYP/TZVP level with the PCM solvent model for both MeCN and
acetone. Specific rotation data and single-point calculations for the
sTDA ECD calculations were run with various functionals (B3LYP,
BH&HLYP, CAM-B3LYP, and PBE0 for the SR and CAM-B3LYP,
LC-BLYP, and ωB97X for the sTDA calculations) and the TZVP
basis set as implemented in the Gaussian 09 package.48 The sTDA
calculations were performed with the sTDA 1.6 package.49 Electronic
circular dichroism spectra were generated as sums of Gaussians with
3000 cm−1 width at half-height, using dipole-velocity-computed
rotational strength values.50 Boltzmann distributions were estimated
from the CAM-B3LYP/TZVP energies. The MOLEKEL software
package was used for visualization of the results.51
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Katalin E. Köveŕ − Department of Inorganic and Analytical
Chemistry, University of Debrecen, H-4032 Debrecen, Hungary
Attila Mándi − Department of Organic Chemistry, University of
Debrecen, H-4032 Debrecen, Hungary; orcid.org/0000-
0002-7867-7084
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Eur. J. Org. Chem. 2012, 2012, 5256−5262.
(13) Polavarapu, P. L.; Jeirath, N.; Kurtań, T.; Pescitelli, G.; Krohn,
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